Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-standardised adult prevalence of diabetes at its 2010 levels. We aimed to estimate worldwide trends in diabetes, how likely it is for countries to achieve the global target, and how changes in prevalence, together with population growth and ageing, are affecting the number of adults with diabetes. We pooled data from population-based studies that had collected data on diabetes through measurement of its biomarkers. We used a Bayesian hierarchical model to estimate trends in diabetes prevalence-defined as fasting plasma glucose of 7.0 mmol/L or higher, or history of diagnosis with diabetes, or use of insulin or oral hypoglycaemic drugs-in 200 countries and territories in 21 regions, by sex and from 1980 to 2014. We also calculated the posterior probability of meeting the global diabetes target if post-2000 trends continue. We used data from 751 studies including 4,372,000 adults from 146 of the 200 countries we make estimates for. Global age-standardised diabetes prevalence increased from 4.3% (95% credible interval 2.4-7.0) in 1980 to 9.0% (7.2-11.1) in 2014 in men, and from 5.0% (2.9-7.9) to 7.9% (6.4-9.7) in women. The number of adults with diabetes in the world increased from 108 million in 1980 to 422 million in 2014 (28.5% due to the rise in prevalence, 39.7% due to population growth and ageing, and 31.8% due to interaction of these two factors). Age-standardised adult diabetes prevalence in 2014 was lowest in northwestern Europe, and highest in Polynesia and Micronesia, at nearly 25%, followed by Melanesia and the Middle East and north Africa. Between 1980 and 2014 there was little change in age-standardised diabetes prevalence in adult women in continental western Europe, although crude prevalence rose because of ageing of the population. By contrast, age-standardised adult prevalence rose by 15 percentage points in men and women in Polynesia and Micronesia. In 2014, American Samoa had the highest national prevalence of diabetes (>30% in both sexes), with age-standardised adult prevalence also higher than 25% in some other islands in Polynesia and Micronesia. If post-2000 trends continue, the probability of meeting the global target of halting the rise in the prevalence of diabetes by 2025 at the 2010 level worldwide is lower than 1% for men and is 1% for women. Only nine countries for men and 29 countries for women, mostly in western Europe, have a 50% or higher probability of meeting the global target. Since 1980, age-standardised diabetes prevalence in adults has increased, or at best remained unchanged, in every country. Together with population growth and ageing, this rise has led to a near quadrupling of the number of adults with diabetes worldwide. The burden of diabetes, both in terms of prevalence and number of adults affected, has increased faster in low-income and middle-income countries than in high-income countries. Wellcome Trust.

Sonata no. 3 in d minor for violin and piano, op. 108

Soitinnus: Viulu, piano.

Suite no. 2 in b minor

Leopold Stokowski and his symphony orchestra.

Rhapsody in B Minor, Op.79, No. 1

Soitinnus: Piano.

Capriccio in B minor, Op. 76, No. 2

Soitinnus: Piano.

Divertimento No. 15, in B flat, K. 287

Soitinnus: Käyrätorvet (2), viulut (2), alttoviulu, kontrabasso.

Intermezzo in B-flat Minor, Op. 117, No. 2

Soitinnus: Piano.

Otimização do banho eletrolítico da liga Fe-W-B resistente à corrosão

A study on optimization of bath parameters for electrodeposition of Fe-W-B alloys from plating baths containing ammonia and citrate is reported. A 2³ full factorial design was successfully employed for experimental design analysis of the results. The corrosion resistance and amorphous character were evaluated. The bath conditions obtained for depositing the alloy with good corrosion resistance were: 0.01 M iron sulfate, 0.10 M sodium tungstate and 0.60 M ammonium citrate. The alloy was deposited at 12% current efficiency. The alloy obtained had Ecorr -0.841 V and Rp 1.463 x 10(4) Ohm cm². The deposit obtained under these conditions had an amorphous character and no microcracks were observed on its surface. Besides this, the bath conditions obtained for depositing the alloy with the highest deposition efficiency were: 0.09 M iron sulfate, 0.30 M sodium tungstate and 0.50 M ammonium citrate. The alloy was deposited at 50% current efficiency, with an average composition of 34 wt% W, 66 wt% Fe and traces of boron. The alloy obtained had Ecorr -0.800 V and Rp 1.895 x 10³ Ohm cm². Electrochemical corrosion tests verified that the Fe-W-B alloy deposited under both conditions had better corrosion resistance than Fe-Mo-B.

Constituintes químicos das cascas do caule de Vochysia thyrsoidea Pohl. (Vochysiaceae) e avaliação das atividades citotóxica e inibitória frente as catepsinas B e K

A new flavonoid, catechin-3-O-(3"-O-trans-cinnamoyl)-α-rhamnopyranoside, along with known compounds, catechin-3-O-α-rhamnopyranoside, 3-oxo-urs-12-en-28-oic acid, 2,4,6-trimethoxybenzoic acid, 2-butyl-D-fructofuranoside and 1-butyl-D-fructofuranoside, has been isolated from the stem bark of V. thyrsoidea. These compounds were assayed for inhibition of protease activity (cathepsins B and K) and against cancer cell lines. Catechin-3-O-(3"-O-trans-cinnamoyl)-α-rhamnopyranoside showed moderate inhibitory activity (IC50 = 62.02 µM) against cathepsin B while 2-butyl-D-fructofuranoside was the most potent against a strain of CNS (SF-295) and human leukemia (HL-60) with IC50 = 36.80 µM and IC50 = 25.37 µM, respectively.

Nanopartículas de poli-hidroxibutirato-co-valerato como suporte para a imobilização da lipase de Candida antarctica fração B

This work evaluates the immobilization of Candida antarctica lipase (Fraction B) using poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) nanoparticles as support. The effects of immobilization time (30-150 min) and pH (5-10) on lipase loading were evaluated. The stability of the immobilized enzyme towards temperature (40, 60, and 80 ºC), reuse and storage (at 4 ºC) were also determined. Furthermore, to assess its potential application in a system of interest, the immobilized lipase was used as a catalyst in the esterification of geraniol with oleic acid. The results indicated a time of 120 minutes and pH of 7 as optimal for immobilization. A 21 hour exposure of the PHBV-lipase derivative to 60 ºC showed a 33% reduction of the initial activity while storage at 4 ºC led to a residual activity (5% of the original activity). The derivative was used without significant loss of activity for 4 successive cycles. The use of the immobilized lipase as a catalyst in the production of geranyl oleate led to about 88% conversion of the initial reactants to products.

Pianokonsertto 27 B, KV. 595

Soitinnus: piano, orkesteri.

Natsien ja kommunistien puhdistuspolitiikka uudessa valossa

Kirjallisuusarvostelu

Prevalência da colonização pelo estreptococo do grupo B em gestantes atendidas em ambulatório de pré-natal

OBJETIVO: verificar a prevalência de estreptococo do grupo B (EGB) em gestantes no terceiro trimestre da gravidez e explorar os fatores potencialmente associados à colonização. MÉTODOS: uma amostra de 273 gestantes no terceiro trimestre da gravidez, provenientes do ambulatório de pré-natal do Hospital Universitário do Sul do Brasil, foi investigada. Culturas de amostra vaginal e anorretal foram obtidas e inoculadas em meio seletivo de Todd-Hewitt suplementado com 10 µg/ml de colistina e 15 µg/ml de ácido nalidíxico e posteriormente subcultivadas em ágar sangue de carneiro desfibrinado. Todas as colônias suspeitas foram submetidas ao teste de aglutinação para detecção do antígeno específico do grupo B. O teste de Camp foi utilizado para identificação do EGB das variedades não hemolíticas. Analisaram-se também os dados demográficos, socioeconômicos, reprodutivos e clínico-obstétricos. A razão de prevalência (RP) foi utilizada como medida de risco. Considerou-se como significante o intervalo de confiança no nível de 95% (alfa=0,05). RESULTADOS: a prevalência de colonização pelo EGB foi de 21,6% (59), sendo que 9,9% (27) das gestantes tiveram positividade em ambos os sítios, 6,95% (19) foram positivas somente no sítio vaginal e 4,75% (13) da amostra tiveram positividade apenas no sítio anal. A prevalência de EGB foi ligeiramente mais alta nas gestantes com idade inferior a 20 anos, naquelas com menor escolaridade e nas gestantes primíparas, e o dobro entre aquelas que não relataram aborto espontâneo, porém sem significância estatística. Não foi encontrada diferença na prevalência de EGB de acordo com história de doenças sexualmente transmissíveis e tabagismo. Quando os dados foram analisados conjuntamente, os fatores detectados como potencialmente associados à colonização pelo EGB foram: primíparas com mais de 30 anos (RP=1,55) e mulheres com mais de um parceiro sexual e freqüência de atividade sexual aumentada (55,6 vs 20,5%; p<0,05). CONCLUSÃO: confirma-se a necessidade rotineira de cultura para EGB em ambos os sítios (vaginal e anal) de todas as gestantes no terceiro trimestre de gestação.